PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
8935.00 - 9125.00
6347.00 - 10045.00
380.0K / 335.9K (Avg.)
23.15 | 391.09
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.26%
Revenue growth of 8.26% vs. zero growth in Healthcare. Walter Schloss might still want to see if it can translate into profits.
13.78%
Gross profit growth of 13.78% while Healthcare median is zero. Walter Schloss might see a slight advantage that could be built upon.
60.88%
EBIT growth of 60.88% while Healthcare median is zero. Walter Schloss would see a marginal edge that could be expanded upon.
78.82%
Operating income growth of 78.82% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand.
59.23%
Net income growth of 59.23% while Healthcare median is zero. Walter Schloss might see potential if moderate gains can keep rising.
55.38%
EPS growth of 55.38% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
55.38%
Diluted EPS growth of 55.38% while Healthcare median is zero. Walter Schloss might see a slight edge that could improve over time.
-0.00%
Share reduction while Healthcare median is 0.00%. Seth Klarman would see a relative advantage if others are diluting.
-0.00%
Diluted share reduction while Healthcare median is 0.00%. Seth Klarman would see an advantage if others are still diluting.
No Data
No Data available this quarter, please select a different quarter.
385.68%
OCF growth of 385.68% while Healthcare is zero. Walter Schloss might see a modest positive difference, which can compound over time.
294.03%
FCF growth of 294.03% while Healthcare median is zero. Walter Schloss might see a slight edge that could compound over time.
10.87%
10Y CAGR of 10.87% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound over very long horizons.
10.87%
5Y CAGR of 10.87% while Healthcare is zero. Walter Schloss might see a slight improvement that could compound if momentum builds.
10.87%
3Y CAGR of 10.87% while Healthcare median is zero. Walter Schloss might see a modest improvement overshadowing the broader sector’s stagnation.
20.32%
OCF/share CAGR of 20.32% while Healthcare median is zero. Walter Schloss might see a modest edge that can add up if momentum improves.
20.32%
OCF/share CAGR of 20.32% while Healthcare median is zero. Walter Schloss might see a slight advantage that can compound if momentum builds.
20.32%
3Y OCF/share growth of 20.32% while Healthcare median is zero. Walter Schloss might see a modest advantage that could compound if momentum holds.
23.37%
Net income/share CAGR of 23.37% while Healthcare median is zero. Walter Schloss might see a marginal edge that can grow if the firm invests wisely.
23.37%
Net income/share CAGR of 23.37% while Healthcare median is zero. Walter Schloss might see a modest advantage that can expand mid-term.
23.37%
3Y net income/share CAGR of 23.37% while Healthcare median is zero. Walter Schloss might see a small advantage that can be scaled further.
22.09%
Equity/share CAGR of 22.09% while Healthcare median is zero. Walter Schloss might see a modest advantage in net worth accumulation that could matter long term.
22.09%
5Y equity/share CAGR of 22.09% while Healthcare median is zero. Walter Schloss sees a slight positive that might compound if management executes well.
22.09%
3Y equity/share CAGR of 22.09% while Healthcare median is zero. Walter Schloss sees a modest short-term advantage that could compound if momentum persists.
-61.67%
Dividend declines over 10 years while Healthcare median is 0.00%. Seth Klarman would see a relative disadvantage if peers consistently raised payouts.
-61.67%
Dividend cuts or stagnation while Healthcare median is 0.00%. Seth Klarman sees a disadvantage in shareholder returns vs. peers.
-61.67%
Dividend reductions while Healthcare median grows. Seth Klarman sees a near-term disadvantage if peers maintain or raise payouts.
No Data
No Data available this quarter, please select a different quarter.
-0.54%
Decreasing inventory while Healthcare is rising. Seth Klarman might see an efficiency advantage or possibly a sign of weaker sales future.
10.14%
Asset growth of 10.14% while Healthcare median is zero. Walter Schloss sees a slight advantage if expansions yield good returns on capital.
6.28%
BV/share growth of 6.28% while Healthcare is zero. Walter Schloss sees a slight lead that can expand if sustained over time.
11.04%
Debt growth of 11.04% while Healthcare median is zero. Walter Schloss might see a modest difference that matters if interest coverage is tight.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.